Silo Pharma, Inc. (SILO) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Silo Pharma reported revenue of $72,102, up 0.0% from $72,102 the year before. Net income was -$4.2M (a -5863.5% net margin), or -$7.50 per diluted share. Gross margin was 38.6% and operating margin was -5937.0%. Operating activities generated -$4.7M of cash. At fiscal year end, Silo Pharma held $7.6M in total assets against $1.3M in total liabilities, including $4.7M of cash and equivalents.
Open the full interactive Silo Pharma financials → Quarterly statements, key ratios, valuation history and price charts.
Silo Pharma Key Stats
| Share Price | $1.22 |
|---|---|
| Market Cap | $1.3M |
| Revenue YoY Growth | +0.0% |
| 52-Week Range | $1.22 – $9.99 |
| Shares Outstanding | 1.1 million (basic, 2026 Q2) |
Silo Pharma Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $40,923 | $2.9M | $72,637 | $72,102 | $72,102 | $72,102 |
| Cost of Goods Sold | $176,126 | — | — | — | — | — |
| Gross Profit | -$135,203 | $66,260 | $66,264 | $66,264 | $66,264 | $27,807 |
| Operating Income | -$2.6M | -$2.7M | -$3.6M | -$3.9M | -$4.7M | -$4.3M |
| Pre-Tax Income | -$3.0M | $4.2M | -$3.9M | -$3.6M | -$4.4M | -$4.2M |
| Income Tax | — | $24,876 | $1,163 | $69,600 | — | — |
| Net Income | -$3.0M | $3.9M | -$3.9M | -$3.7M | -$4.4M | -$4.2M |
| Diluted EPS | -$37.50 | $30.00 | -$25.67 | -$18.02 | -$17.85 | -$7.50 |
Silo Pharma Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $18,025 | $18,026 | $18,026 | — |
| Net Income | -$1.1M | -$881,530 | -$1.6M | -$832,829 |
| Diluted EPS | -$1.80 | -$0.11 | -$1.80 | -$0.76 |
Silo Pharma Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.1M | $9.8M | $11.4M | $3.5M | $3.9M | $4.7M |
| Current Assets | $1.4M | $10.4M | $11.6M | $7.7M | $7.1M | $7.4M |
| Total Assets | $1.4M | $10.5M | $11.6M | $7.7M | $7.4M | $7.6M |
| Current Liabilities | $141,723 | $490,039 | $436,318 | $775,590 | $1.7M | $650,183 |
| Total Long-Term Debt | $18,900 | $44,134 | $81,474 | $81,474 | — | — |
| Total Liabilities | $145,969 | $1.4M | $1.3M | $1.6M | $2.4M | $1.3M |
| Shareholders' Equity | $1.3M | $9.1M | $10.3M | $6.2M | $5.0M | $6.3M |
Silo Pharma Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$1.2M | -$2.3M | -$3.5M | -$3.2M | -$3.8M | -$4.7M |
| Cash From Investing | $39,000 | $7.2M | $86,707 | -$4.1M | $973,777 | $644,021 |
| Cash From Financing | $2.1M | $3.8M | $4.9M | -$471,121 | $3.2M | $4.9M |
Figures from Silo Pharma's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Silo Pharma financials page for every line item.
Silo Pharma Company Profile
| Ticker | SILO |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Sarasota, Florida |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001514183 |
Frequently Asked Questions
What was Silo Pharma's revenue in fiscal 2025?
Silo Pharma (SILO) reported revenue of $72,102 for fiscal 2025.
What is Silo Pharma's annual revenue history?
Silo Pharma's annual revenue by fiscal year: 2020: $40,923; 2021: $2.9M; 2022: $72,637; 2023: $72,102; 2024: $72,102; 2025: $72,102.
What was Silo Pharma's net income in fiscal 2025?
Silo Pharma reported net income of -$4.2M for fiscal 2025.
What was Silo Pharma's earnings per share (EPS) in fiscal 2025?
Silo Pharma's diluted EPS was -$7.50 for fiscal 2025 (adjusted for any later stock splits).
How many shares of Silo Pharma are outstanding?
Silo Pharma reported a weighted average of 1.1 million basic shares outstanding in 2026 Q2.
What is Silo Pharma's market cap?
Based on its latest closing price, Silo Pharma (SILO) has a market capitalization of about $1.3M.
When does Silo Pharma's fiscal year end?
Silo Pharma's fiscal year end, as registered with the SEC, is December 31.
Where is Silo Pharma headquartered?
Silo Pharma lists its business address in Sarasota, Florida in its SEC filings.